Clinical trial
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed…
NCT00002895 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00002895 |
|---|---|
| Title | Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer |
| Official title | A Randomised Trial in Relapsed Ovarian Cancer: Early Treatment Based on CA 125 Levels Alone Vs. Delayed Treatment Based On Conventional Clinical Indicators |
| Lead sponsor | Medical Research Council, Other |
| Collaborators | European Organisation for Research and Treatment of Cancer - EORTC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | chemotherapy |
| Enrollment | 1,400 |
| Start date | Jun 1, 1996 |
| Completion | Oct 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 4, 2013 |
| Countries | Austria, Belgium, France, Ireland, Italy, Netherlands, Portugal, South Africa, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: